Alzheimer’s Treatment Center of America (ATCA)
- ATCA addresses many cognitive impairment and mild cognitive impairment issues. In the documented 2½ year trial using our patented protocol: up to 76% of the patients either had no further decline or, even better, had improvement in their mild cognitive impairment. Most care is covered by Medicare.
WHAT IS MILD COGNITIVE IMPAIRMENT?
Mild cognitive impairment causes changes to cognitive abilities that are noticeable by a person and their family, but do not impact the person’s ability to independently complete daily activities. It is quite common among adults 65 and older, impacting about 15-20%.
Those living with MCI are more likely to develop Alzheimer’s Disease or other dementia, although it does not always develop into dementia and sometimes even reverses. It is important to seek medical care as soon as possible for prompt diagnosis and treatment
Top Symptoms of MCI
There are two common classifications of MCI, amnestic and non-amnestic.
Amnestic MCIs primarily impact memory, and a person may forget important information that previously would have been easy to recall, such as conversations or commitments.
Non-amnestic MCIs, alternatively, impacts non-memory thinking skills, including decision making and judgement or visual awareness.
Treatment for MCI
No medications are currently FDA approved for the treatment of MCI. However, early diagnosis is important so that progress can be regularly assessed, and interventions can target the brain before irreversible damage has occurred. New research continues to focus on the benefits of early action.
Experts believe that many, though not all, MCI cases are a result of brain damage associated with early stages of Alzheimer’s disease or other dementias. Learn more
WHAT IS COGNITIVE IMPAIRMENT?
Cognitive impairment is when a person has challenges with memory, learning new things, concentration, or judgement that affects their daily lives. It can range from mild impairment to severe. In severe cases, one can lose the ability to understand, talk, or write and may no longer be able to live alone.
Cognitive impairment is not caused by any one disease. It can be associated with Alzheimer’s disease and dementia, strokes, traumatic brain injuries, and more.
Early Warning Signs of Cognitive Impairment
The most common symptoms include memory loss, repetition of stories or questions, changes in mood, not recognizing or forgetting familiar people and places, vision problems, difficulty with judgement or planning for everyday tasks.
ALZHEIMER’S TREATMENT CENTERS OF AMERICA has built upon existing therapeutic advances with new data-driven technology to create a patented personalized treatment approach that is more successful than anything currently on the market.
Alzheimer’s Treatment Center of America (ATCA) offers a breakthrough, evidence-based treatment protocol designed by leading experts in medicine, science, and technology.
Our cutting-edge approach has been proven very effective. In the documented 2½ year trial using our patented protocol: up to 76% of the patients either had no further decline or, even better, had improvement in their mild cognitive impairment. Most of this care is covered by Medicare.
- ATCA offers a novel, personalized strategy, driven by an original artificial intelligence algorithm in combination with medical specialists, genetic testing, and nutritional guidelines.Between visits, the ATCA telemedicine software enables the therapy team to track progress, answer questions, and adjust the plan in real time. Our clinic specialists, including health coaches, dieticians, and more, are always just a phone call away.In addition to traditional remedies, ATCA is constantly integrating the latest tools including non-pharmaceutical components (e.g., supplements), dietary and behavioral changes for optimal healing. Our specialists also track clinical trials and other experimental treatments to remain at the cutting edge of Alzheimer’s treatment.
How The ATCA Process Works
⦁ Schedule Initial Consult
In order to protect you from coronavirus all of our visits will be via Telemedicine until the Health Emergency is over. A simple to use video conference will be set up between the practitioner and the patient and/or the caregivers. These are scheduled for 45 minutes.
⦁ Complete Personal and Family Medical History
After the appointment is scheduled, we will email the patient and/or caregiver some online forms to fill out. Once these are filled out you will be ready to have the visit with the practitioner.
⦁ Initial Office Visit (online)
All of the information submitted will be reviewed and assessed by the practitioner. Additional information will be gathered by the practitioner during the office visit. Based upon that review, the practitioner will order labs and memory tests.
⦁ Blood Draws and Memory Tests
A mobile phlebotomist will come to your home to draw your blood and take your vital signs. The medical assistant will send the patient and caregiver a link for the memory tests. These memory tests will be taken online.
⦁ All Data Assessment and Report Creation
Our practitioner along with our Artificial Intelligence (AI) analytical tool will complete a baseline health assessment using: personal medical history, family medical history, genomic sequencing identifying pertinent genetic mutations, blood tests, memory evaluations, and more. A comprehensive 15 page report will then be created.
⦁ Get Your Personalized Care Plan
Our Patented proprietary AI rules engine will propose a set of prioritized interventions, based on your unique circumstances. Of course, the care plan will be reviewed and adjusted by our team of medical experts before being finalized. The care plan will be presented to the patient and/or caregiver in a 30 minute video conference.
⦁ Regular Care Management and Coaching
Multiple times each month our Health Coaches will work with the patients and caregivers to ensure that the prescribed protocol is being followed. Clarifications will be made where needed.
⦁ Monitor and Adjust
Our treatment plans are not static. They are adjusted based on continuous collection of new information, including patient reaction, side effects, new labs, biometric trends, and more.